Evidence map›Paper›PMID 36235669›Full record

ArticleNutrients2022

The Role of Infant Formulas in the Primary Prevention of Allergies in Non-Breastfed Infants at Risk of Developing Allergies-Recommendations from a Multidisciplinary Group of Experts.

Jorge Amil Dias, Edmundo Santos, Inês Asseiceira, Sylvia Jacob, Carmen Ribes Koninckx

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Jorge Amil DiasPaediatric Gastroenterology, Hospital Lusíadas, 4050-115 Porto, Portugal.
Edmundo SantosNeonatology Unit, Hospital de São Francisco Xavier-Centro Hospitalar de Lisboa Ocidental, 1349-019 Lisboa, Portugal.
Inês AsseiceiraLaboratório de Nutrição, Faculdade de Medicina de Lisboa, Centro Hospitalar Universitário Lisboa Norte, 1649-028 Lisbon, Portugal.ORCID 0000-0002-0621-5657
Sylvia JacobPaediatric Allergology Unit, Centro Hospitalar Universitário São João, 4200-319 Porto, Portugal.
Carmen Ribes KoninckxPaediatric Gastroenterology & Hepatology & Instituto de Investigacion Sanitaria, Hospital Universitario y Politecnico La Fe, 46026 Valencia, Spain.
Centro Hospitalar de Lisboa Ocidental · PTCentro Hospitalar Lisboa Norte · PTHospital de São João · PTInstituto de Investigación Sanitaria La Fe · ESLusíada University of Porto · PT

Funding

Danone Nutricia The expert meetings that informed this position paper were funded by Danone Nutricia.
6 · The paper itself

Abstract

The worldwide incidence of allergic diseases has been continuously increasing, and up to one in every five people are currently affected by these medical conditions. Although seldom fatal, allergies have a profound impact on children's growth, development, and quality of life, besides being associated with heavy healthcare costs and resource utilisation. In this context, a group of experts in nutrition, paediatric gastroenterology, allergology, and neonatology joined forces to discuss the role of infant formulas in the primary prevention of allergies in infants for whom breastfeeding is not an option and who are at risk of developing allergies. The topics discussed included the assessment of risk, the impact of the microbiota on the modulation of immune tolerance, and the added value of certain formula characteristics, namely, protein integrity (hydrolysed protein vs. intact protein) and the addition of prebiotics, probiotics, or synbiotics. This article describes the latest evidence on each of the above-mentioned points, as well as a number of recommendations made by the experts to guide counselling of parents in the choice of a formula for infants at risk of allergy. Overall, the experts highlighted family history and dysbiosis-promoting factors (namely, caesarean delivery and antibiotic use) as two of the most important risk factors for allergy development. Moreover, in line with international guidelines, the panel advocated that intact protein formula should be offered to all bottle-fed healthy infants, irrespective of their allergic risk (with the exception of short-term bottle feeding of otherwise breastfed babies in their first week of life, for whom a hydrolysed formula may be advisable). Finally, the experts agreed that the use of prebiotic-, probiotic-, or synbiotic-enriched formulas should be considered in infants at risk of developing allergies.

Indexed as

Food HypersensitivityMilk HypersensitivityAnti-Bacterial AgentsBreast FeedingChildFemaleHumansInfantInfant FormulaPrebioticsPrimary PreventionQuality of LifeAnti-Bacterial AgentsPrebioticshydrolysed formulasprebioticsprimary prevention of allergyprobioticssynbiotics

Identifiers

PMID36235669
PMCPMC9572163
OpenAlexW4297523353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.